202 related articles for article (PubMed ID: 30314955)
1. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer.
Lancellotta V; Kovács G; Tagliaferri L; Perrucci E; Rembielak A; Stingeni L; Tramontana M; Hansel K; Colloca G; Saldi S; Valentini V; Aristei C
J Geriatr Oncol; 2019 May; 10(3):514-517. PubMed ID: 30314955
[TBL] [Abstract][Full Text] [Related]
2. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
4. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.
Guix B; Finestres F; Tello J; Palma C; Martinez A; Guix J; Guix R
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):95-102. PubMed ID: 10758310
[TBL] [Abstract][Full Text] [Related]
5. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy in lip carcinoma: long-term results.
Guibert M; David I; Vergez S; Rives M; Filleron T; Bonnet J; Delannes M
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e839-43. PubMed ID: 21163589
[TBL] [Abstract][Full Text] [Related]
7. The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review.
Alam M; Nanda S; Mittal BB; Kim NA; Yoo S
J Am Acad Dermatol; 2011 Aug; 65(2):377-388. PubMed ID: 21496952
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy.
Ducassou A; David I; Filleron T; Rives M; Bonnet J; Delannes M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):726-31. PubMed ID: 21435798
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced skin cancers of the frail and elderly: consider adaptive split-course radiotherapy.
Fogarty GB; McLaren KR; Moutrie Z; Poon TSC; Izard MA
Br J Dermatol; 2018 Dec; 179(6):1416-1417. PubMed ID: 30117147
[No Abstract] [Full Text] [Related]
10. Interstitial high-dose-rate brachytherapy in eyelid cancer.
Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
[TBL] [Abstract][Full Text] [Related]
11. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
12. High dose-rate versus low dose-rate brachytherapy for lip cancer.
Ghadjar P; Bojaxhiu B; Simcock M; Terribilini D; Isaak B; Gut P; Wolfensberger P; Brömme JO; Geretschläger A; Behrensmeier F; Pica A; Aebersold DM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1205-12. PubMed ID: 22099044
[TBL] [Abstract][Full Text] [Related]
13. A novel conformal superficial high-dose-rate brachytherapy device for the treatment of nonmelanoma skin cancer and keloids.
Ferreira C; Johnson D; Rasmussen K; Leinweber C; Ahmad S; Jung JW
Brachytherapy; 2017; 16(1):215-222. PubMed ID: 27720205
[TBL] [Abstract][Full Text] [Related]
14. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
[TBL] [Abstract][Full Text] [Related]
15. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
[TBL] [Abstract][Full Text] [Related]
16. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
17. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report.
Ouhib Z; Kasper M; Perez Calatayud J; Rodriguez S; Bhatnagar A; Pai S; Strasswimmer J
Brachytherapy; 2015; 14(6):840-58. PubMed ID: 26319367
[TBL] [Abstract][Full Text] [Related]
18. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
19. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.
Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M
Radiother Oncol; 2008 Jun; 87(3):383-90. PubMed ID: 18501454
[TBL] [Abstract][Full Text] [Related]
20. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
